MASH's economic burden is substantial, particularly for patients with MASH and multiple comorbidities, even in the absence of cirrhosis. Metabolic dysfunction–associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis...
Gastroenterology
RELEVANT ARTICLES IN Gastroenterology
Costly Comorbidities Persist for the 90% of Patients With MASH and No Cirrhosis
Costly Comorbidities Persist for the 90% of Patients With MASH and No Cirrhosis
MASH's economic burden is substantial, particularly for patients with MASH and multiple comorbidities, even in the absence of cirrhosis.
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
TUESDAY, Sept. 10, 2024 (HealthDay News) -- Omission of 5-fluorouracil (5-FU) from the first-line FOLFOX, FOLFIRI, and FOLFIRINOX regimens is not associated with reduced survival among patients with advanced colorectal, gastroesophageal, and pancreatic cancers,...
Advertisement
Effective Internet-Based ECBT Reduces IBS Symptoms and Avoidance Behaviors
Effective Internet-Based ECBT Reduces IBS Symptoms and Avoidance Behaviors
The following is a summary of “Internet delivered exposure based cognitive behavior therapy for IBS – A clinical effectiveness study,” published in the August 2024 issue of Gastroenterology by Walllen et al. Irritable bowel syndrome (IBS), a prevalent and...
Clinical Practice Guideline Developed for Treatment of H. Pylori Infection
Clinical Practice Guideline Developed for Treatment of H. Pylori Infection
MONDAY, Sept. 9, 2024 (HealthDay News) -- In a clinical practice guideline issued by the American College of Gastroenterology and published in the September issue of the American Journal of Gastroenterology, recommendations are presented for the treatment of...
Most Patients With Stage I PDAC Are Upstaged on Histopathology
Most Patients With Stage I PDAC Are Upstaged on Histopathology
MONDAY, Sept. 9, 2024 (HealthDay News) -- More than 70 percent of patients with stage I pancreatic ductal adenocarcinoma (PDAC) and close to 30 percent with stage II PDAC are upstaged on histopathology, according to a research letter published online Sept. 5 in the...
Costly Comorbidities Persist for the 90% of Patients With MASH and No Cirrhosis
Costly Comorbidities Persist for the 90% of Patients With MASH and No Cirrhosis
MASH's economic burden is substantial, particularly for patients with MASH and multiple comorbidities, even in the absence of cirrhosis.
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
TUESDAY, Sept. 10, 2024 (HealthDay News) -- Omission of 5-fluorouracil (5-FU) from the first-line FOLFOX, FOLFIRI, and FOLFIRINOX regimens is not associated with reduced survival among patients with advanced colorectal, gastroesophageal, and pancreatic cancers,...
Effective Internet-Based ECBT Reduces IBS Symptoms and Avoidance Behaviors
Effective Internet-Based ECBT Reduces IBS Symptoms and Avoidance Behaviors
The following is a summary of “Internet delivered exposure based cognitive behavior therapy for IBS – A clinical effectiveness study,” published in the August 2024 issue of Gastroenterology by Walllen et al. Irritable bowel syndrome (IBS), a prevalent and...
Clinical Practice Guideline Developed for Treatment of H. Pylori Infection
Clinical Practice Guideline Developed for Treatment of H. Pylori Infection
MONDAY, Sept. 9, 2024 (HealthDay News) -- In a clinical practice guideline issued by the American College of Gastroenterology and published in the September issue of the American Journal of Gastroenterology, recommendations are presented for the treatment of...
Most Patients With Stage I PDAC Are Upstaged on Histopathology
Most Patients With Stage I PDAC Are Upstaged on Histopathology
MONDAY, Sept. 9, 2024 (HealthDay News) -- More than 70 percent of patients with stage I pancreatic ductal adenocarcinoma (PDAC) and close to 30 percent with stage II PDAC are upstaged on histopathology, according to a research letter published online Sept. 5 in the...
Advertisement
CONDITION SPOTLIGHTS
Condition Spotlight: Crohn’s & Colitis
A collection of feature articles, study abstracts, and additional resources all focused on Crohn’s disease and colitis.
Crohn’s & Colitis Congress 2024
The latest news from Crohn’s & Colitis Congress 2024, including abstracts, features, and helpful conference information.
Advertisement
Crohn’s Disease
Physician’s Weekly-created content featuring key opinion leaders sharing their perspectives on Crohn’s disease from different vantage points.
Helping Patients Keep Their Dignity in Their Final Moments
Helping Patients Keep Their Dignity in Their Final Moments
Tips for how physicians can help their patients who are in the process of dying approach death with dignity, and the value of providing hospice care.
Stop Physician Burnout: the Hidden Danger of AI Note Writing Software
Stop Physician Burnout: the Hidden Danger of AI Note Writing Software
AI note writing software offers physicians short-term stress relief, but physician stress may shift to employer demand for increased patient quotas.
Medications in Obesity Treatment: Types, Benefits, and Considerations
Medications in Obesity Treatment: Types, Benefits, and Considerations
Dr. Jill Bryson explains which medications can be beneficial when incorporated into an obesity treatment plan, and factors that determine medication use.
PODCAST
Advertisement
MORE STORIES IN GASTROENTEROLOGY
FILTER ARTICLES BY:
Advertisement
PODCAST
CARTOONS
Elbowing In
Elbowing In
Medical cartoon in which man needs an elbow specialist, but meets Joint Chief of Staff.
Big Pill to Swallow
Big Pill to Swallow
Medical cartoon in which the pharmacist is giving the customer a prescription bottle containing one huge, once-a-year pill.
BUSINESS OF MEDICINE
Drawing the Line When “Curbsiding”
Drawing the Line When “Curbsiding”
Dr. MedLaw discusses where the line between safely offering informal consultation, or "curbsiding," and taking on the liability of a consultation gets drawn.
How Cash-Based Healthcare May Benefit Both Patients and Physicians
How Cash-Based Healthcare May Benefit Both Patients and Physicians
Cash-based healthcare aims to provide all individuals with vital healthcare services, eliminating the burden of navigating insurance company requirements.
What the Re-Classification of Cannabis as a Schedule III Drug Means for Physicians
What the Re-Classification of Cannabis as a Schedule III Drug Means for Physicians
Physicians should educate themselves on the benefits of medical marijuana, recognizing that cannabis may soon be re-classified as a Schedule III drug.
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.